Pular para o conteúdo
Merck
  • Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.

Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.

International journal of pharmaceutics (2013-06-26)
Keita Kondo, Natsuki Ito, Toshiyuki Niwa, Kazumi Danjo
RESUMO

We attempted to prepare sustained release fine particles using a two-step mechanical powder processing method; particle-shape modification and dry particle coating. First, particle shape of bulk drug was modified by mechanical treatment to yield drug crystals suitable for the coating process. Drug crystals became more rounded with increasing rotation speed, which demonstrates that powerful mechanical stress yields spherical drug crystals with narrow size distribution. This process is the result of destruction, granulation and refinement of drug crystals. Second, the modified drug particles and polymer coating powder were mechanically treated to prepare composite particles. Polymer nanoparticle agglomerate obtained by drying poly(meth)acrylate aqueous dispersion was used as a coating powder. The porous nanoparticle agglomerate has superior coating performance, because it is completely deagglomerated under mechanical stress to form fine fragments that act as guest particles. As a result, spherical drug crystals treated with porous agglomerate were effectively coated by poly(meth)acrylate powder, showing sustained release after curing. From these findings, particle-shape modification of drug crystals and dry particle coating with nanoparticle agglomerate using a mechanical powder processor is expected as an innovative technique for preparing controlled-release coated particles having high drug content and size smaller than 100 μm.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Theophylline, anhydrous, ≥99%, powder
Sigma-Aldrich
Poly(methacrylic acid, sodium salt) solution, average Mn ~5,400, average Mw ~9,500 by GPC, 30 wt. % in H2O
Sigma-Aldrich
Poly(methacrylic acid, sodium salt) solution, average Mw 4,000-6,000, 40 wt. % in H2O
Supelco
Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material
Theophylline, European Pharmacopoeia (EP) Reference Standard